Canada Pension Plan Investment Board Galapagos Nv Transaction History

Canada Pension Plan Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $2.69 Million - $3.26 Million	-57,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $3.47 Million - $4.2 Million	-50,400 Reduced 46.88%	57,100 $3.93 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $8.19 Million - $12 Million	107,500 New	107,500 $8.29 Million
Q1 2020 May 13, 2020	SELL	$143.0 - $274.03 $339,911 - $651,369	-2,377 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $347,327 - $513,004	2,377 New	2,377 $492,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.84B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.